advertisement
9.4.1 Steroid-induced glaucoma (51)
Showing records 1 to 25
Display all abstracts in classification 9.4.1 Steroid-induced glaucoma
Search within classification 9.4.1 Steroid-induced glaucoma67253 Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure
Sheppard JD
Advances in Therapy 2016; 33: 532-552
67264 Topical ocular dexamethasone decreases intraocular pressure and body weight in rats
Sato K
Journal of negative results in biomedicine 2016; 15: 5
67529 A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study
Moss EB
Journal of Glaucoma 2017; 26: 182-186
67280 Vernal Keratoconjunctivitis in Kashmir: A temperate zone
Sofi RA
International Ophthalmology 2016; 36: 875-879
67523 Racial Influences of Uveitic Glaucoma: Consolidation of Current Knowledge of Diagnosis and Treatment
Gregory AC
Seminars in Ophthalmology 2016; 0: 0
66790 Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats
Gosling AA
Veterinary Ophthalmology 2016; 19: 69-76
66704 Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide
Chan LW
Journal of Glaucoma 2016; 25: e268-e272
67597 Triamcinolone Acetonide and Bevacizumab Induced Raised Intraocular Pressure in An Elderly Male Diabetic Patient - A Case Report
Golakiya HN
Current drug safety 2016; 0:
66753 Ocular changes induced by drugs commonly used in dermatology
Turno-Kręcicka A
Clinics in Dermatology 2016; 34: 129-137
67271 SUBRETINAL CANNULATION AS A COMPLICATION OF SUTURE TRABECULOTOMY SURGERY IN A PEDIATRIC PATIENT
Wise J
Retinal cases & brief reports 2017; 11: 79-82
66828 Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
Borrás T
Gene Therapy 2016; 23: 438-449
67529 A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study
Buys YM
Journal of Glaucoma 2017; 26: 182-186
66704 Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide
Hsu WC
Journal of Glaucoma 2016; 25: e268-e272
67271 SUBRETINAL CANNULATION AS A COMPLICATION OF SUTURE TRABECULOTOMY SURGERY IN A PEDIATRIC PATIENT
Toygar O
Retinal cases & brief reports 2017; 11: 79-82
66753 Ocular changes induced by drugs commonly used in dermatology
Grzybowski A
Clinics in Dermatology 2016; 34: 129-137
67597 Triamcinolone Acetonide and Bevacizumab Induced Raised Intraocular Pressure in An Elderly Male Diabetic Patient - A Case Report
Hirapara HN
Current drug safety 2016; 0:
67264 Topical ocular dexamethasone decreases intraocular pressure and body weight in rats
Nishiguchi KM
Journal of negative results in biomedicine 2016; 15: 5
66790 Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats
Kiland JA
Veterinary Ophthalmology 2016; 19: 69-76
66828 Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
Buie LK
Gene Therapy 2016; 23: 438-449
67280 Vernal Keratoconjunctivitis in Kashmir: A temperate zone
Mufti A
International Ophthalmology 2016; 36: 875-879
67253 Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure
Comstock TL
Advances in Therapy 2016; 33: 532-552
67523 Racial Influences of Uveitic Glaucoma: Consolidation of Current Knowledge of Diagnosis and Treatment
Zhang MM
Seminars in Ophthalmology 2016; 0: 0
66753 Ocular changes induced by drugs commonly used in dermatology
Misiuk-Hojło M
Clinics in Dermatology 2016; 34: 129-137
67529 A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study
Low SA
Journal of Glaucoma 2017; 26: 182-186
66828 Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
Spiga MG
Gene Therapy 2016; 23: 438-449
